UTAH MEDICAL (UTMD) finance chief reports 50-share stock gift

Rhea-AI Filing Summary

UTAH MEDICAL PRODUCTS INC principal financial officer Brian Koopman reported a bona fide gift transfer of 50 shares of Common Stock. The gifted shares were valued at $66.27 per share for reporting purposes. Following the gift, he directly holds 782 shares of the company’s stock.

Insider Trade Summary

50 shares gifted

Mixed 1 txn

Insider Koopman Brian

Role Principal Financial Officer

Type	Security	Shares	Price	Value
Gift	Common Stock	50	$66.27	$3K

Holdings After Transaction: Common Stock — 782 shares (Direct, null)

Footnotes (1)

Key Figures

Gifted shares: 50 shares Reported share value: $66.27 per share Shares owned after transaction: 782 shares +1 more

4 metrics

Gifted shares 50 shares Bona fide gift of Common Stock

Reported share value $66.27 per share Value used for the 50-share gift

Shares owned after transaction 782 shares Direct holdings following the gift

Gift transactions count 1 gift, 50 shares Transaction summary for this Form 4

Key Terms

bona fide gift, Common Stock, Principal Financial Officer, Form 4, +1 more

5 terms

bona fide gift financial

"The transaction code G carries the description "bona fide gift"."

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

Common Stock financial

"The reported security title for the transaction is Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Principal Financial Officer financial

"Brian Koopman is identified with the officer title Principal Financial Officer."

The principal financial officer is the senior executive who runs a company's financial operations: preparing and certifying financial reports, managing accounting controls, budgets and cash flow, and advising on financial strategy. Investors care about this role because its competence affects how trustworthy the company’s numbers are, how well it manages risk and capital needs, and the credibility of forecasts—like the chief navigator steering a firm's financial course.

Form 4 regulatory

"This insider transaction is disclosed in a Form 4 filing."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code G regulatory

"The filing uses transaction code G, defined as a bona fide gift."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koopman Brian

(Last) (First) (Middle)

108 E 1700 S

(Street)

BOUNTIFUL UTAH 84010

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UTAH MEDICAL PRODUCTS INC [ UTMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		G		50	D	$66.27	782	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian L. Koopman	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did UTMD's Brian Koopman report on this Form 4?

Brian Koopman reported a bona fide gift of 50 shares of UTAH MEDICAL PRODUCTS INC Common Stock. This was a non-market transaction classified as a gift transfer rather than a purchase or open-market sale.

What was the share value used for Brian Koopman’s UTMD stock gift?

The 50 gifted UTAH MEDICAL PRODUCTS INC shares were reported at a value of $66.27 per share. This price is used for Form 4 reporting and does not represent proceeds from an open-market sale.

How many UTMD shares does Brian Koopman hold after the reported gift?

After the reported bona fide gift, Brian Koopman directly holds 782 shares of UTAH MEDICAL PRODUCTS INC Common Stock. This figure reflects his remaining direct ownership position following the 50-share disposition.

Is Brian Koopman’s UTMD Form 4 transaction a sale of shares?

No, the Form 4 classifies the transaction as a bona fide gift, not an open-market sale. The transaction code G and description "bona fide gift" indicate a non-cash transfer rather than a sale for proceeds.

What role does Brian Koopman hold at UTAH MEDICAL PRODUCTS INC (UTMD)?

Brian Koopman is identified as the Principal Financial Officer of UTAH MEDICAL PRODUCTS INC. His Form 4 filing reports a personal stock gift transaction in the company’s Common Stock under his direct ownership.